For a patient with gallbladder adenomyomatosis and a 3 mm sessile gallbladder polyp, should cholecystectomy be performed or is imaging follow‑up sufficient?

Management of Gallbladder Adenomyomatosis with 3mm Sessile Polyp

For a patient with gallbladder adenomyomatosis and a 3mm sessile polyp, no surgery is indicated and no follow-up imaging is required.

Rationale Based on Current Evidence

Adenomyomatosis is Benign and Requires No Intervention

Adenomyomatosis is a benign condition characterized by hyperplasia of the gallbladder wall with Rokitansky-Aschoff sinuses 1. Recent high-quality evidence confirms that adenomyomatosis does not require follow-up, even for larger lesions 2. In a 2026 study examining 144 patients with adenomyomatosis over a median follow-up of 35 months, none developed gallbladder carcinoma, confirming that these are definitively benign lesions 2. The study concluded that follow-up is not needed for lesions with a clear diagnosis of focal adenomyomatosis.

The 3mm Polyp is Below All Risk Thresholds

The 2022 Society of Radiologists in Ultrasound (SRU) guidelines—the most authoritative and recent consensus—establish clear size-based management 1:

• Polyps ≤5mm without risk factors: No follow-up required 1
• Multiple large studies demonstrate 0% malignancy risk in polyps ≤5mm 1
• In a survey of SRU fellows representing approximately 3 million gallbladder ultrasounds, no documented cases of malignancy were found in polyps <10mm at initial detection or during follow-up 1

The 2022 European guidelines (ESGAR/EAES/EFISDS/ESGE) similarly recommend no follow-up for polyps ≤5mm in patients without risk factors for malignancy 3.

Sessile Morphology Does Not Change Management at This Size

While sessile morphology is associated with higher malignancy risk in larger polyps 1, 4, this becomes relevant only when polyps reach concerning sizes (≥10mm). At 3mm, the absolute malignancy risk remains essentially zero regardless of morphology 1.

Clinical Algorithm

Step 1: Confirm the diagnosis

• Adenomyomatosis should show characteristic features: hypoechoic/isoechoic wall thickening with Rokitansky-Aschoff sinuses (appearing as anechoic spaces or containing microliths), often with comet-tail artifacts 1, 5
• If diagnosis is uncertain, MRI can definitively demonstrate cystic-like Rokitansky-Aschoff sinuses 1

Step 2: Measure the polyp accurately

• At 3mm, this is well below the 5mm threshold where any intervention is considered

Step 3: Assess for symptoms

• If the patient has biliary-type symptoms (right upper quadrant pain, nausea after fatty meals), consider whether adenomyomatosis or the polyp could be causative
• However, only diffuse symptomatic adenomyomatosis occasionally requires cholecystectomy 5

Step 4: Document and reassure

• No follow-up imaging is needed
• Patient can be reassured that both findings are benign

Important Caveats

Risk Factors That Would Change Management (Not Applicable Here)

The following would warrant surveillance even for small polyps, but only if the polyp were 5-9mm 3:

• Age >60 years
• Primary sclerosing cholangitis
• Asian ethnicity
• Sessile morphology with focal wall thickening >4mm

At 3mm, even these risk factors do not justify follow-up 3.

When Surgery Would Be Indicated

Cholecystectomy would only be appropriate if 1, 3:

• The polyp measures ≥10mm
• The patient has severe symptoms clearly attributable to the gallbladder with no other explanation
• The polyp grows to ≥10mm or shows rapid growth (≥4mm within 12 months) during surveillance

Common Pitfalls to Avoid

1. Over-surveillance: The surgical risk of cholecystectomy (2-8% morbidity, including 0.3-0.6% risk of bile duct injury; 0.2-0.7% mortality) far exceeds the malignancy risk of a 3mm polyp 1

2. Misidentifying tumefactive sludge: If there's any doubt about whether this represents a true polyp versus sludge, short-interval follow-up ultrasound in 1-2 months with optimized technique can clarify 1

3. Unnecessary anxiety: Up to 83% of apparent polyps ≤5mm seen on ultrasound are not found at subsequent cholecystectomy, suggesting many are artifacts or adherent material 1

Evidence Quality Assessment

The recommendation is based on:

• High-quality 2022 consensus guidelines from the Society of Radiologists in Ultrasound published in Radiology 1
• Updated 2022 European multi-society guidelines published in European Radiology 3
• Large population studies including 35,856 patients showing cancer rates of only 1.3 per 100,000 for polyps <6mm 1
• Recent 2026 data specifically addressing adenomyomatosis confirming its benign nature 2

The evidence strongly and consistently supports conservative management with no intervention for this clinical scenario.